Related Experiment Video
Updated: May 5, 2026
07:20
Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy
Published on: August 9, 2024
3.0K
Magnesium sulfate for cerebral palsy prevention
Dwight J Rouse1, Karen J Gibbins
1Brown University Alpert School of Medicine, Women & Infants Hospital, Providence, RI 02905.
Seminars in Perinatology
|December 3, 2013
Summary
Administering magnesium sulfate (MgSO4) to high-risk mothers can prevent cerebral palsy in preterm infants. This safe and effective treatment reduces cerebral palsy rates by 32%.
Area of Science:
- Obstetrics and Gynecology
- Neonatal Neurology
- Pharmacology
Background:
- Cerebral palsy (CP) is a significant concern in infants born preterm.
- Early preterm delivery poses a high risk for developing CP.
- Magnesium sulfate (MgSO4) is a potential neuroprotective agent.
Purpose of the Study:
- To evaluate the efficacy of magnesium sulfate (MgSO4) in preventing cerebral palsy (CP) in high-risk preterm infants.
- To assess the safety and feasibility of using MgSO4 in clinical practice for neuroprotection.
Main Methods:
- Analysis of three large, randomized placebo-controlled trials.
- Inclusion of data from a subsequent Cochrane Review.
- Evaluation of clinical practice implementation.
Main Results:
- Magnesium sulfate (MgSO4) demonstrated a 32% reduction in cerebral palsy rates.
- The number needed to treat (NNT) was 63 to prevent one case of CP.
- Clinical practice evaluation confirmed feasibility and cost-effectiveness.
Conclusions:
- Magnesium sulfate (MgSO4) is a proven intervention for reducing cerebral palsy in at-risk preterm infants.
- The drug is familiar to obstetricians and possesses an excellent safety profile.
- Simple protocols support its effective and economical clinical application.
Related Concept Videos
01:31Skeletal Muscle Relaxants: Therapeutic Uses
1.2K
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
1.2K
01:21Skeletal Muscle Relaxants: Adverse Effects
1.2K
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
1.2K
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
1.8K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.8K
01:28Classification of Skeletal Muscle Relaxants
3.6K
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
3.6K
01:29Spasmolytic Agents: Chemical Classification
1.5K
Spasmolytic agents are drugs used to alleviate muscle spasms and spasticity. They can be categorized into different chemical groups based on their mechanisms of action. Centrally acting spasmolytics primarily affect the spinal cord, while others directly target skeletal muscle cells.
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
1.5K
01:14Antiepileptic Drugs: Glutamate Antagonists
1.3K
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.3K